DocMeetings

New Pathways and Chemotherapeutic Delivery Mechanisms in the Treatment of Metastatic Breast Cancer

Metastatic breast cancer (mBC) remains the leading cause of cancer-related death in women. Chemotherapy remains the backbone of mBC treatment; however, new developments across the therapeutic spectrum are expanding clinical approaches to care. Among chemotherapy agents, efforts are underway to improve delivery mechanisms, efficacy, and toxicity profiles, with a shift towards oral therapy, but how do we balance value, costs and health improvements?

Join AJMC® on December 17th, to gain insights from leaders from organizations such as West Cancer Center and Stanford Cancer Centers as they discuss shifting treatment paradigm in mBC, and their approach to ensuring success with oral therapy.

Learning Objectives:

-Explore unmet treatment needs and innovations in metastatic breast cancer, particularly the developing spectrum of chemotherapeutic interventions

-Educate oncology community on emerging therapies in mBC with an emphasis on oral therapy

-Discuss benefits and challenges of oral therapy, including the impact of COVID-19 on uptake